Becton Dickinson (XTER:BOX) FFO


XTER:BOX Becton Dickinson & Co XTER:BOX
77 GF Score
Price €133.15
GF Value €166.14
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Becton Dickinson FFO?

FFO (Funds from operations) only applies to REITs.

XTER:BOX
77GF Score
Becton Dickinson & Co XTER:BOX
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Becton Dickinson (XTER:BOX) Overvalued in 2026?

Based on GuruFocus' analysis, Becton Dickinson stock appears to be undervalued. The current stock price of €133.15 is trading 19.9% below its estimated GF Value™ of €166.14. GuruFocus considers Becton Dickinson to be Modestly Undervalued.

Key valuation signals for XTER:BOX:

  • FFO:
  • GF Value™: €166.14 vs. price of €133.15 (19.9% below fair value)
  • GF Score™: 77/100 with 3 warning signs

No single metric tells the full story. See the XTER:BOX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Becton Dickinson Business Description

Address 1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
77GF Score

Get the complete analysis for XTER:BOX

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€133.15
Price
€166.14
GF Value